Monday, July 18, 2016

UPDATE 1-Brainstorm's cell therapy succeeds in ALS mid-stage study

July 18 (Reuters) - Brainstorm Cell Therapeutics Inc

said its experimental cell therapy was safe and well

tolerated in patients with amyotrophic lateral sclerosis (ALS),

a progressive neurological...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)